Navigation Links
Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results
Date:3/13/2008

- Conference Call/Webcast at 4:30 p.m. Eastern Time Today -

IRVINE, Calif., March 13 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular patient temperature management therapies, today reported on its corporate progress and financial results for the fourth quarter and year ended December 31, 2007.

Revenue for the fourth quarter of 2007 was a record $2.7 million, compared to $2.0 million in the fourth quarter of 2006. Revenue for the full year 2007 was also a record of $9.1 million, compared to $6.0 million in 2006. These results were due to growth in sales of intravascular temperature management systems, as well as increased sales of catheters due to the growing installed base.

"We are proud to report our strongest quarter and year in Alsius history, which is a direct result of our continued investment in developing the leading intravascular temperature management solutions," said Bill Worthen, President and CEO of Alsius. "Our customers are becoming increasingly aware of the importance of precise temperature management in critically ill patients and recognize the value of our technology as the right solution. Our efforts in 2008 will be focused on continuing to develop the market for our products -- increasing awareness of the importance of temperature management and the benefits of our technology versus conventional approaches."

Additional Fourth Quarter and Full Year 2007 Financial Results

In the fourth quarter of 2007, gross profit was $0.8 million, compared to $0.3 million in the fourth quarter of 2006. For the full year 2007, gross profit was $1.8 million, compared to a loss of $0.2 million for the same period the prior year.

Total operating
'/>"/>

SOURCE Alsius Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Alsius Corporation to Host Third Quarter 2007 Financial Results Conference Call/Webcast on November 13, 2007
2. Alsius Corporation Announces Program for Early Exercise of Warrants
3. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
4. Brooke Franchise Corporation Announces Selected July Results
5. MedThink Communications Retained by NanoBio Corporation
6. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
7. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
11. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2013)... 2013 Temperatures hovered close to freezing ... of Universal Studios Hollywood backlot, famously featured in the ... was heard, volunteer runners began simultaneous 10K and 5K ... movie sets such as Bates Motel, ‘Psycho’ House, Jaws ... of the Worlds, before finishing back in the Square. ...
(Date:12/9/2013)... (PRWEB) December 10, 2013 Today, iFitDress.com, a ... special occasion dresses, has added 500 discounted evening dresses ... the company, each of these outfits is guaranteed to be ... , It is true that these new evening dresses create ... is a leading brand in the industry. It has a ...
(Date:12/9/2013)... Christi, TX (PRWEB) December 09, 2013 ... a more intense sedation dentistry option to ... dentists and dental procedures. Until recently, Dr. Richards only ... provides a third option that combines the two therapies ... patients with less severe anxiety, Dr. Richards may recommend ...
(Date:12/9/2013)... 09, 2013 Half Dental of Utah has ... not have or cannot afford dental insurance. The company ... (such as the removal of wisdom teeth in ... insurance. By providing this payment plan, Half Dental hopes ... going into debt. The practice allows patients to also ...
(Date:12/9/2013)... MillionaireCasket.com, a leading casket company from China, today announces ... Now, all its solid wood caskets are offered at ... CEO of the company, the special offer is valid ... solid wood caskets from MillionaireCasket.com are available in a ... according to customers' requirements. MillionaireCasket.com’s product catalog is now ...
Breaking Medicine News(10 mins):Health News:Team Narconon Runners Swell the Ranks of the Say No to Drugs Race Holiday Classic on Universal Studios Backlot 2Health News:New Discounted Evening Dresses Added To iFitDress.com, A Famous Dress Company 2Health News:Dr. Tilman Richards Is Now Offering Sedation Dentistry in Corpus Christi, TX 2Health News:Half Dental—Leaders For Mouth Restoration In St. George—Offer New Payment Plans For Patients 2Health News:Custom Solid Wood Caskets Come With Big Discounts - MillionaireCasket.com 2
... move to lift a ban on abortion has born fruit with ... ban being lifted or, legalizing abortion. , Portugal ... abortion or destruction of unborn children, due to religious convictions. ... prison term and those who aid them are likewise prosecuted. ...
... have struck the honeybee population across the country killing thousand ... by this weird ailment. This has adversely affected the commercial ... reported a loss of at least half of their bee ... many beehives and their populations in US. Though such incidences ...
... Pakistani authorities on Thursday expressed confidence in their efforts to ... strain of bird flu, after two separate incidents at poultry ... yet not over [for bird flu], but we have sufficient ... with any sporadic cases that might occur," Muhammad Afzal, a ...
... have created a new type of nanoparticle that could ... of food products, as well as for medical diagnosis. ... the journal Nanotechnology. ,Nanoparticles, according to Ian ... engineering and senior author of a paper describing the ...
... has been recognized resulting in tests that could spot potential ... ,Professor Philippe Froguel of Imperial College, London ... hereditary and life style patterns are linked to type 2 ... genetic test that would envisage people who would be more ...
... significantly increases a woman’s risk of becoming infected with ... 1st edition of The Journal of Infectious Diseases (now ... several sexually transmitted infections increase the risk of transmission ... cases of Trichomonas vaginalis per year worldwide, there are ...
Cached Medicine News:Health News:Pakistan: Authorities Plays Down Bird Flu Risk 2Health News:UC Davis Creates New Nanoparticles 2Health News:Vaginalis Increases the Risk of Becoming Infected With HIV 2Health News:Vaginalis Increases the Risk of Becoming Infected With HIV 3
(Date:12/9/2013)... and OSAKA, Japan , Dec. 9, ... wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A. , ... from the Gastrointestinal Drugs and Drug Safety and Risk ... (U.S.) Food and Drug Administration (FDA) voted ... of adults with moderately to severely active ulcerative colitis ...
(Date:12/9/2013)... 9, 2013  Ambit Biosciences (Nasdaq: AMBI ), ... drugs targeting unmet needs in oncology, autoimmune and inflammatory ... 55 th Annual ASH Conference in ... drug candidate, quizartinib.  Results of ... of Quizartinib in Subjects with FLT3-ITD Positive Relapsed Acute ...
(Date:12/9/2013)... Dec. 9, 2013  Janssen Research & Development, LLC ... The Lancet Oncology, evaluating the safety and ... over the age of 65 with previously untreated chronic ... N=2). The study met its primary endpoint of safety, ... therapy was associated with adverse events (AEs) that were ...
Breaking Medicine Technology:FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab 2FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab 3FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab 4FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab 5Ambit Announces Presentations At The 55th Annual Meeting Of The American Society Of Hematology (ASH) 2Ambit Announces Presentations At The 55th Annual Meeting Of The American Society Of Hematology (ASH) 3Ambit Announces Presentations At The 55th Annual Meeting Of The American Society Of Hematology (ASH) 4Ambit Announces Presentations At The 55th Annual Meeting Of The American Society Of Hematology (ASH) 5Ambit Announces Presentations At The 55th Annual Meeting Of The American Society Of Hematology (ASH) 6Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65 2Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65 3Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65 4Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65 5Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65 6Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65 7Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65 8Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65 9
... , NEW HAVEN, Conn., ,Dec. 14 /PRNewswire-FirstCall/ ... today announced that it had received a complete response ... related to its New Drug Application ("NDA") for Onrigin(TM) ... indicates that the FDA cannot approve the Company,s NDA ...
... , , , CLAREMONT, Calif., Dec. ... McKenna College today released the analysis of social responsibility ... report contains a compilation of Pacific Sustainability Index (PSI) ... companies. Scoring is based on the transparency, intent, and ...
Cached Medicine Technology:Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 2New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 3
... Solutions Medonic 620 3-Part Differential; 16-Parameter ... fast, reliable and accurate patient outcomes ... include; open and closed vial sampling ... patient identification with the ability to ...
... Bio-Rad Mumps IgG test is an enzyme immunoassay ... are obtained after a 90-minute incubation. The ... permitting uniformity of reporting. The Bio-Rad Mumps ... semi-quantitative detection of human IgG antibodies to mumps ...
... for Toxoplasmosis has progressed from ... dye test to immunoflourescence, latex ... In addition to Toxo ... both Toxo IgM immunocapture and ...
Serology provides a minimally-invasive, sensitive and easy-to-perform method for the determination of H. pylori infection. The Bio-Rad H. pylori qualitative test kits use EIA technology for the deter...
Medicine Products: